您的位置: 首页 > 农业专利 > 详情页

Medical use of Shindecan-2
专利权人:
オルブセン セラピューティクス リミテッド
发明人:
エリマン,ステファン ヨセフ,エリマン,ステファン ヨセフ
申请号:
JP2016508166
公开号:
JP6438457B2
申请日:
2014.04.16
申请国别(地区):
JP
年份:
2018
代理人:
摘要:
SDC2, compositions that comprise SDC2, vectors encoding SDC2 and compounds that modulate expression of SDC2 by cells are used for treatment of mammalian, e.g. human, cells to achieve immunomodulation or for other specific therapeutic interventions. Cells are treated by combining the cells with SDC2, treating the cells with an antibody or fragment thereof that binds SDC2 or modulating expression or activity of SDC2 by the cells. Cells or tissue are derived from treated cells for therapeutic uses based on their immunomodulatory or other therapeutic properties.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充